stock

Medical Device BPO Services That Drive Device Adoption, Protect Patient Safety, & Scale With Your Program

Ameridial delivers HIPAA-compliant medical device BPO services across the full device lifecycle — patient onboarding and education, technical support, order management, RPM engagement, post-market feedback intake, and regulatory complaint and recall support — for medical device manufacturers, DME suppliers, digital health companies, and connected health platforms.
pharmacy-contact-center
stock_C
stock_a

Medical Device BPO Services Across the Full Device Lifecycle — From Patient Onboarding to Post-Market Compliance

Medical device companies operate at the intersection of healthcare, technology, and regulation. Adoption is not guaranteed by product performance alone. For devices to succeed in the real world — to be used correctly, consistently, and safely — they must be surrounded by support infrastructure that can guide patients through onboarding, answer technical questions without crossing into clinical advice, manage order and logistics inquiries at scale, and capture post-market feedback, complaints, and adverse event reports in a manner that meets FDA documentation obligations. Building this infrastructure internally is resource-intensive, difficult to scale, and carries regulatory risk if processes are inconsistently executed. Ameridial’s medical device BPO services are designed to carry this operational load — providing trained, non-clinical specialist teams, structured workflows, and AI-enhanced quality oversight that protect device programs, brand trust, and patient safety simultaneously.

Ameridial supports medical device manufacturers, DME suppliers, and digital health companies across six service areas: device customer and patient support, patient onboarding and device education, Tier 1 technical support (non-clinical), remote patient monitoring (RPM) engagement support, order management and logistics coordination, and post-market feedback and adverse event intake. For regulated complaint handling and adverse event reporting, Ameridial’s intake workflows are designed to operate in alignment with FDA 21 CFR Part 803 (Medical Device Reporting) documentation requirements — capturing complaint data accurately, routing to internal quality and regulatory teams, and supporting MDR-obligated reporting timelines. All services are delivered in HIPAA-compliant, SOC 2 Type II-audited, and PCI DSS 4.0.1-certified environments with 24/7/365 support availability.

MedTech Companies We Support

Ameridial’s medical device BPO services are tailored to the compliance requirements, support complexity, and patient population characteristics of each MedTech company type — from high-volume DME operations to regulated post-market support for Class II and Class III device manufacturers.
Prescription-refill

Medical Device Manufacturers

Support device manufacturers with patient onboarding, customer support, technical helpdesk, and post-market feedback intake — operating within FDA-aligned complaint handling workflows that protect product integrity, support MDR documentation requirements, and maintain the non-clinical boundaries required for compliance.

Insurance

DME Suppliers

Deliver scalable customer support, order management, and logistics coordination for durable medical equipment suppliers — managing high-volume inbound inquiries, delivery status requests, setup support, and insurance coordination workflows across CPAP, mobility, diabetes, and other DME product lines.

Prior Authorization

Digital Health & Connected Health Platforms

Support RPM platforms, connected health apps, and digital therapeutics with patient onboarding, engagement and adherence outreach, app and connectivity troubleshooting, and program participation follow-up — non-clinical BPO support that improves activation rates and sustains long-term user engagement.

bilingual

Diabetes, Sleep Apnea & Specialty Device Companies

Provide high-touch patient support for diabetes device companies (CGM, insulin delivery), sleep apnea and CPAP manufacturers, and specialty device brands — with agents trained on device-specific onboarding protocols, consumable reorder workflows, connectivity troubleshooting, and program adherence engagement.

Medical Device BPO Service Capabilities

Ameridial’s medical device BPO services span the full device lifecycle — from first patient contact and onboarding through ongoing engagement, technical support, order management, and FDA-aligned post-market regulatory intake. All services are non-clinical and delivered within HIPAA-compliant, AI-monitored contact centre environments.
Prescription-refill

Medical Device Customer Service & Remote Monitoring Support

Inbound and outbound customer support for device users, caregivers, and program participants — managing product enquiries, usage questions, programme enrolment, and remote monitoring support across approved channels with trained, device-aware agents.

Insurance

Patient Onboarding & Device Education Support

Guided device setup, usage education, and programme orientation using manufacturer-approved scripts and materials — improving first-use confidence, reducing setup errors, and accelerating device adoption for patients and caregivers.

Prior Authorization

Medical Device Technical Support (Tier 1 — Non-Clinical)

First-level troubleshooting, error code interpretation, connectivity support, and escalation coordination for device-related issues — resolving common hardware, software, and integration problems within non-clinical scope, with clear escalation pathways to manufacturer technical and clinical teams.

bilingual

Medical Device Order Tracking & Fulfilment Support

Support for order intake, fulfilment coordination, delivery status tracking, and logistics enquiries — ensuring patients and providers have accurate, timely information on device orders and replacements while reducing inbound contact volume to manufacturer operations teams.

communication

Medical Device Adverse Event Reporting & Complaint Intake

Structured complaint intake and adverse event reporting support aligned to FDA 21 CFR Part 803 (MDR) documentation requirements — capturing device complaints, safety reports, and adverse event data accurately, routing to internal quality and regulatory teams, and supporting manufacturers' MDR-obligated reporting timelines.

Prescription Delivery

Medical Device Recall Notification Services

Outbound patient and provider notification support for device recalls, field safety corrective actions (FSCAs), and product advisories — reaching affected device users across communication channels with manufacturer-approved messaging and documenting notification completion for regulatory records.

Care Success Stories

See how Ameridial partners with healthcare organizations to solve challenges, streamline processes, and elevate patient engagement through proven BPO strategies.

Case study
163% Increase in Prescription Fulfillment

AI Technology That Strengthen Medical
Device BPO Performance

Ameridial integrates AI tools across medical device BPO workflows — monitoring every patient interaction for quality and regulatory compliance, automating routine device and order enquiries, and providing agents with real-time guidance on FDA-aligned complaint handling and technical support protocols.

AI QMS
Monitors 100% of medical device support interactions for quality, compliance, and documentation accuracy — including adverse event intake calls, technical support escalations, and recall notification contacts — with real-time flagging for any interaction requiring supervisor or regulatory review.
Conversational AI
Automates high-volume routine device enquiries — order status, delivery tracking, programme enrolment, device compatibility FAQs, and appointment reminders — reducing agent workload and ensuring consistent, manufacturer-approved responses at scale.
Accent Harmonizer
Enhances real-time voice clarity in patient support calls — particularly important for device setup and usage instruction, where miscommunication on technical steps can affect device performance and patient safety.
arya
Delivers live agent guidance on FDA-aligned complaint intake protocols, manufacturer-approved device troubleshooting scripts, non-clinical boundary reminders, and escalation triggers — reducing documentation errors and ensuring consistent adverse event and recall handling across every interaction.
AI
AI-Solutions-Designed-for-Smarter-Pharmacy-Engagement

Why Choose Ameridial
for Medical Device BPO Services

MedTech companies choose Ameridial as their medical device BPO partner for the combination of regulatory-aware support design, device-trained specialist teams, FDA-aligned complaint intake workflows, and the HIPAA-compliant, AI-monitored contact centre infrastructure that high-stakes device programs require.

Why Choose prior authorization support
hipaa

Experience in Regulated Healthcare & Life Sciences

37 years of healthcare BPO experience operating within HIPAA, FDA-aligned, and life sciences regulatory environments — giving medical device manufacturers a support partner that understands compliance boundaries, documentation obligations, and the consequences of non-compliant complaint handling.
trained agent

Non-Clinical Boundary Discipline

Rigorous agent training, workflow design, and quality monitoring maintain the non-clinical boundary required for medical device BPO — ensuring that support interactions never enter clinical decision-making territory while still providing technically accurate, empathetic device assistance.
Scalable-Support

Scalable Across Launch, Growth & Global Expansion

Flexible delivery models that scale from pilot programme launches to national rollouts and global multi-language deployments — supporting MedTech companies at every stage of the device lifecycle without the overhead of building internal support operations to match each growth phase.
Device Industry Expertise

Device-Trained & Safety-Aware Agent Workforce

Specialist agents trained on device-specific onboarding protocols, manufacturer-approved troubleshooting scripts, FDA adverse event documentation standards, and non-clinical boundary requirements — not general customer service representatives applying a healthcare overlay.
Integrated-AI

HIPAA-Compliant, FDA-Aligned Infrastructure

All medical device BPO services operate within HIPAA-certified, SOC 2 Type II-audited, and PCI DSS 4.0.1-compliant infrastructure, with complaint intake workflows designed to support FDA MDR documentation requirements and adverse event data integrity standards.
Real-Time

Outcome-Oriented Reporting Aligned to Device Programs

Custom KPI dashboards and SLA reporting tailored to device programme metrics — adoption rates, first-call resolution, onboarding completion, complaint intake accuracy, recall notification reach, and patient engagement — giving MedTech operations leaders the performance visibility their programmes require.
PCI Certified

PCI DSS 4.0.1

bsi-27001

ISO 27001:2022

HIPPA

HIPAA Compliant

AICIPA SOC 2

SOC 2 Type II

MBE-Certification

MBE

Get in Touch Today

    Frequently Asked Questions (FAQs)

    Ameridial aligns MedTech services to device safety standards, regulatory expectations, and real-world user needs—ensuring scalable support without clinical risk.

    floating-obj
    Ameridial provides six medical device BPO service areas: Medical Device Customer Service and Remote Monitoring Support; Patient Onboarding and Device Education; Tier 1 Technical Support (non-clinical); Medical Device Order Tracking and Fulfilment Support; Adverse Event Reporting and Complaint Intake (aligned to FDA 21 CFR Part 803); and Medical Device Recall Notification Services. DME Support Services is also available for durable medical equipment suppliers. All services are non-clinical and delivered within HIPAA-compliant, SOC 2 Type II-audited environments.

    Ameridial’s adverse event intake workflows are designed to operate in alignment with FDA 21 CFR Part 803 (Medical Device Reporting) requirements. Trained agents follow manufacturer-approved intake scripts to capture complete complaint data, classify reportability, and route information accurately to the manufacturer’s internal quality and regulatory teams. Ameridial does not make MDR reportability determinations — that responsibility remains with the manufacturer’s regulatory team — but our structured intake and documentation processes are designed to support manufacturers’ MDR-obligated reporting timelines and MAUDE submission workflows.

    No. Ameridial provides non-clinical customer support, technical assistance, onboarding coordination, and regulatory intake services only. All clinical assessment, diagnosis, or medical decision-making remains exclusively with licensed healthcare professionals. Agent training, workflow design, and AI-assisted quality monitoring all enforce this non-clinical boundary during every interaction.
    Ameridial supports medical device manufacturers (including Class II and Class III device companies), DME suppliers (CPAP, mobility devices, diabetes devices, home health equipment), digital health and RPM platform providers, connected health companies, and specialty device manufacturers. Within MedTech, Ameridial has particular experience supporting diabetes device companies, sleep apnea and CPAP suppliers, diagnostic and monitoring device companies, and mobility device providers.

    Most medical device BPO programmes launch within 4–8 weeks, depending on device complexity, manufacturer-specific script and protocol development, system integration requirements, and programme scope. FDA-aligned adverse event intake programmes may require additional time for workflow validation and agent compliance training. Recall notification programmes can typically be activated on accelerated timelines given the urgency of recall events — Ameridial’s implementation team is experienced in rapid deployment for time-sensitive device safety communications.

    Still have questions?
    Schedule a consultation with our team.

    Healthcare Insights

    Discover healthcare insights worth reading—designed to inform, inspire,
    & transform how you connect payers, providers, and patients.